NanoGroup S.A. (WSE:NNG)

Poland flag Poland · Delayed Price · Currency is PLN
3.010
-0.150 (-4.75%)
Feb 6, 2025, 5:00 PM CET
227.17%
Market Cap 85.78M
Revenue (ttm) 724.25K
Net Income (ttm) -5.17M
Shares Out 28.13M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,643
Average Volume 25,547
Open 3.170
Previous Close 3.160
Day's Range 3.010 - 3.170
52-Week Range 0.892 - 4.370
Beta 1.27
RSI 48.57
Earnings Date Apr 25, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2024, NanoGroup's revenue was 724,249, an increase of 35771.67% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.

Financial Statements

News

There is no news available yet.